BNP Paribas Financial Markets’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $5.75M | Buy |
|
|||||
|
2023
Q1 | $3.07M | Buy |
|
|||||
|
2022
Q4 | $1.11M | Sell |
|
|||||
|
2022
Q3 | $1.55M | Sell |
|
|||||
|
2022
Q2 | $2.49M | Buy |
|
|||||
|
2022
Q1 | $1.87M | Buy |
|
|||||
|
2021
Q4 | $908K | Buy |
|
|||||
|
2021
Q3 | $2.21M | Buy |
|
|||||
|
2021
Q2 | $845K | Buy |
|
|||||
|
2021
Q1 | $113K | Buy |
|
|||||
|
2020
Q4 | $99K | Buy |
|
|||||
|
2020
Q3 | $46.8K | Sell |
|
|||||
|
2020
Q2 | $1.07M | Sell |
|
|||||
|
2020
Q1 | $1.08M | Buy |
|
|||||
|
2019
Q4 | $648K | Sell |
|
|||||
|
2019
Q3 | $296K | Buy |
|
|||||
|
2019
Q2 | $242K | Sell |
|
|||||
|
2019
Q1 | $375K | Buy |
|
|||||
|
2018
Q4 | $9.99K | Sell |
|
|||||
|
2018
Q3 | $62.7K | Buy |
|
|||||
|
2018
Q2 | $20.4K | Sell |
|
|||||
|
2018
Q1 | $50.4K | Buy |
|
|||||
|
2017
Q4 | $68.3K | Buy |
|
|||||
|
2017
Q3 | $26.5K | Sell |
|
|||||
|
2017
Q2 | $29.3K | Buy |
|
|||||
|
2017
Q1 | $1.93K | Sell |
|
|||||
|
2016
Q4 | $6K | Sell |
|
|||||
|
2016
Q3 | $10.4K | Buy |
|
|||||
|
2016
Q2 | $4.44K | Buy |
|